Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions
Condition(s):22q11.2 Deletion SyndromeLast Updated:April 27, 2017Completed
Hide Studies Not Open or Pending
Condition(s):22q11.2 Deletion SyndromeLast Updated:April 27, 2017Completed
Condition(s):Ear Malformations in the Velocardiofacial SyndromeLast Updated:November 2, 2008Completed
Condition(s):Di George SyndromeLast Updated:October 5, 2020Recruiting
Condition(s):Velocardiofacial Syndrome; Williams Syndrome; Fragile X SyndromeLast Updated:November 3, 2020Recruiting
Condition(s):Velocardiofacial SyndromeLast Updated:October 21, 2016Completed
Condition(s):Complete DiGeorge Anomaly; DiGeorge Syndrome; DiGeorge Anomaly; Complete DiGeorge SyndromeLast Updated:July 16, 2020Available
Condition(s):22q11.2 Deletion SyndromeLast Updated:January 9, 2020Terminated
Condition(s):DiGeorge Syndrome; Velocardiofacial Syndrome; 22q11.2 SyndromeLast Updated:July 2, 2017Completed
Condition(s):DiGeorge Anomaly; DiGeorge Syndrome; Complete DiGeorge Anomaly; Complete DiGeorge SyndromeLast Updated:March 9, 2020Completed
Condition(s):22q11.2 Deletion SyndromeLast Updated:December 2, 2020Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.